Viewing Study NCT04620304


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2025-12-30 @ 6:23 AM
Study NCT ID: NCT04620304
Status: COMPLETED
Last Update Posted: 2023-04-24
First Post: 2020-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients
Sponsor: United BioPharma
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-01-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-05-25
Primary Completion Date Type: ACTUAL
Completion Date: 2022-05-25
Completion Date Type: ACTUAL
First Submit Date: 2020-10-22
First Submit QC Date: None
Study First Post Date: 2020-11-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-21
Last Update Post Date: 2023-04-24
Last Update Post Date Type: ACTUAL